The VARD (Videoendoscopic Assisted Retroperitoneal Drainage) approach as treatment for necrotizing pancreatitis proposes an alternative to standard complicated open abdomen treatment methods.

This treatment involves making a small incision and looking inside the abdomen with a videoendoscope. A videoendoscope is an instrument with a small camera and light on the end. It also has an extension tool that the surgeon can use to clean out any dead and infected tissue in the abdomen.

This approach may reveal a treatment opportunity with faster recovery potential and shorter hospitalizations for patients with necrotizing pancreatitis.

Condition	Treatment or Intervention	Phase
Pancreatitis, Acute Necrotizing	Procedure: Videoscopic-Assisted Retroperitoneal Debridement (VARD)	Phase II

Further Study Details: 

Expected Total Enrollment:  40

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

• Pancreatic necrosis or peripancreatic fluid collection following acute pancreatitis noted on CT scan
• Infected pancreatic necrosis or pancreatic abscess and determined by + FNA (gram stain or culture), as defined by the Atlanta Symposium
• Not neutropenic or pregnant
• No prior necrosectomy
• No pancreatic pseudocyst, either sterile or infected

Karen D. Horvath, MD      206-543-2241    khorvath@u.washington.edu
Rosemary J. Mitchell, BS      206-543-9322    mitchell@u.washington.edu

Oregon
      Oregon Health Sciences University, Portland,  Oregon,  97239,  United States; Recruiting
      Veteran's Administration-Portland, Portland,  Oregon,  97239,  United States; Recruiting
Washington
      University of Washington, Seattle,  Washington,  98195,  United States; Recruiting
      Harborview Medical Center, Seattle,  Washington,  98104,  United States; Recruiting
      Veteran's Administration Puget Sound, Seattle,  Washington,  98108,  United States; Recruiting
Canada, Ontario
      University of Toronto, Toronto,  Ontario,  Canada; Not yet recruiting

Study ID Numbers:  VDIPC
Record last reviewed:  January 2005
Last Updated:  January 7, 2005
Record first received:  May 22, 2003
ClinicalTrials.gov Identifier:  NCT00061269
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08